Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

fH1 DSP 0546LP

Next Previous
Drug Profile

fH1 DSP 0546LP

Alternative Names: fH1/​DSP-0546LP

Latest Information Update: 02 Jul 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Nationwide Institute of Pharmaceutical Sciences, Well being and Vitamin; Sumitomo Pharma
  • Class Influenza virus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Influenza virus infections

Most Recent Events

  • 18 Jun 2024 Preclinical trials in Influenza virus infections in Japan (IM) (Sumitomo Pharma pipeline, June 2024)
  • 14 Jun 2024 Sumitomo Pharma plans a phase I trial for Influenza virus infections (Prevention) in Belgium (IM) (NCT06460064)
  • 14 May 2024 Sumitomo Pharma enters into R&D agreement with Nationwide Institute of Pharmaceutical Sciences, Well being and Vitamin (NIBIOHN) for the development of influenza vaccine candidate fH1/DSP-0546LP

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top